Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Fraser

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Journal of Hepatology|November 21, 2017
The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimenHamish Innes, Stephen T Barclay, Peter C Hayes, et al.
Alimentary Pharmacology & Therapeutics|April 15, 2020
Mortality and morbidity of locally acquired hepatitis E in the national Scottish cohort: a multicentre retrospective studySebastian J Wallace, Rachael Swann, Mhairi Donnelly, et al.
The American Journal of Gastroenterology|August 16, 2022
Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?Hamish Innes, Victoria Hamill, Scott A McDonald, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2011
A primer on the current state of microarray technologiesAlexander J Trachtenberg, Jae-Hyung Robert, Azza E Abdalla, et al.
Alimentary Pharmacology & Therapeutics|June 4, 2019
Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005-2016: a national database linkage studyScott A McDonald, Stephen T Barclay, Sharon J Hutchinson, et al.
Journal of Viral Hepatitis|November 8, 2019
Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosisScott A McDonald, Kevin G Pollock, Stephen T Barclay, et al.
BMJ Open Gastroenterology|January 7, 2022
Effect of COVID-19 on presentations of decompensated liver disease in ScotlandThomas Manship, Paul N Brennan, Iona Campbell, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from careHamish A Innes, Sharon J Hutchinson, Samuel Allen, et al.
Journal of Hepatology|August 23, 2016
Mortality in hepatitis C patients who achieve a sustained viral response compared to the general populationHamish Innes, Scott McDonald, Peter Hayes, et al.
Drug and Alcohol Dependence|July 18, 2015
Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfectionHeather Valerio, David J Goldberg, James Lewsey, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Journal of Hepatology|November 21, 2017
The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimenHamish Innes, Stephen T Barclay, Peter C Hayes, et al.
Alimentary Pharmacology & Therapeutics|April 15, 2020
Mortality and morbidity of locally acquired hepatitis E in the national Scottish cohort: a multicentre retrospective studySebastian J Wallace, Rachael Swann, Mhairi Donnelly, et al.
The American Journal of Gastroenterology|August 16, 2022
Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?Hamish Innes, Victoria Hamill, Scott A McDonald, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 2, 2011
A primer on the current state of microarray technologiesAlexander J Trachtenberg, Jae-Hyung Robert, Azza E Abdalla, et al.
Alimentary Pharmacology & Therapeutics|June 4, 2019
Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005-2016: a national database linkage studyScott A McDonald, Stephen T Barclay, Sharon J Hutchinson, et al.
Journal of Viral Hepatitis|November 8, 2019
Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosisScott A McDonald, Kevin G Pollock, Stephen T Barclay, et al.
BMJ Open Gastroenterology|January 7, 2022
Effect of COVID-19 on presentations of decompensated liver disease in ScotlandThomas Manship, Paul N Brennan, Iona Campbell, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
Excess liver-related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from careHamish A Innes, Sharon J Hutchinson, Samuel Allen, et al.
Journal of Hepatology|August 23, 2016
Mortality in hepatitis C patients who achieve a sustained viral response compared to the general populationHamish Innes, Scott McDonald, Peter Hayes, et al.
Drug and Alcohol Dependence|July 18, 2015
Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: Implications for reinfectionHeather Valerio, David J Goldberg, James Lewsey, et al.
Pageof 7